This is a snippet of the transcript, sign up to read more.
The advantage of being associated with Brookfield and having the credit capacity and commitments that Brookfield can secure is that it's not challenging for them to attract capital. This puts them in a position to participate in massive transactions where there are only one or two bidders. For instance, take Isagen, which was a deal involving all the Colombian hydro assets. It was a competition between themselves and another bidder. At that level, due to the high price tag, Bruce Flatt, the CEO, actually became an active participant. This was a departure from past practices, but it was a necessary step given the scale of the deal.
This is a snippet of the transcript, sign up to read more.
Any asset that was acquired would be leveraged. They have a strong relationship with the capital markets community, including life insurance companies and sizable banks around the world. When I was with them, we had a renewable credit facility that consisted of 20 different banks from around the world. They have limitless capital to deploy. The challenge every year is to find acquisitions. They have teams of people looking for distressed assets and seizing those opportunities.
This is a snippet of the transcript, sign up to read more.
Yes. That situation changed, likely the year before I left. When I was there, we went through approximately five different restructurings in how we dealt with things, primarily due to the sheer volume of work. What it eventually evolved into was having an executive team for Canada; by country, essentially. Initially, it was going to be by continent, but then I believe they further subdivided it by country. For instance, you would have a CFO and a CEO of Brookfield Renewable Canada. The idea was to assemble an M&A team at the country level, enabling them to move more swiftly due to the increasing number of opportunities. Consider the investment climate a few years ago when cash was incredibly cheap. It was an attractive prospect. They continuously identified opportunities.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.